Abstract
412.5: Outcomes of the RIVASTIM: Rapamycin randomized controlled trial of immunosuppression modification to improve vaccine responses in kidney transplant recipients.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have